Sweden raises estrogen drug prices to lure foreign manufacturers amid shortage

Sweden's TLV approved price increases for estrogen medications to attract foreign manufacturers and address a domestic shortage. The move signals a policy shift toward market-based incentives in pharmaceutical supply resilience. Impact depends on manufacturer response and speed of supply restoration.